• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Eaton Vance Tax Advantaged Dividend Inc

Eaton Vance Tax Advantaged Dividend Inc

  1. All
  2. 3rd Party
  1. Evotec AG: LAB282 Accelerates with Second Round Funding

    Evotec AG: LAB282 Accelerates with Second Round Funding

  2. Evotec Announces Strategic Investment in Facio Therapies to Support Development of Novel FSHD Therapy

    Evotec Announces Strategic Investment in Facio Therapies to Support Development of Novel FSHD Therapy

  3. Evotec Joins NURTuRE Consortium to Mine Unique Kidney Disease Patient Biobank

    Evotec Joins NURTuRE Consortium to Mine Unique Kidney Disease Patient Biobank

  4. Resolutions of the Annual General Meeting 2017 of Evotec AG

    Resolutions of the Annual General Meeting 2017 of Evotec AG

12

©2017 Morningstar Advisor. All right reserved.